| CYP2C9、CYP2C19、CYP3A4基因多态性对磺脲类降糖药代谢的影响 |
| |
| 引用本文： | 李赟,何芳,曾彩雯,刘林林,夏春华.CYP2C9、CYP2C19、CYP3A4基因多态性对磺脲类降糖药代谢的影响[J].金属学报,2012,17(5):582-587. |
| |
| 作者姓名： | 李赟 何芳 曾彩雯 刘林林 夏春华 |
| |
| 作者单位： | 1.南昌大学医学院临床药理研究所,南昌 330006,江西;2.江西护理职业技术学院, 南昌 330201,江西 |
| |
| 基金项目： | 国家自然科学基金(81060275, 81160411);国家十二五重大专项(2011ZX09302-007-03);江西省自然科学基金(2009GZY0141) |
| |
| 摘 要： | 磺脲类口服降糖药在人体内主要经过肝脏代谢。肝脏中的细胞色素氧化酶P450是一种重要的药物代谢酶系统,在人群中存在基因多态性,导致药物疗效和不良反应在个体间存在着较大的差异。本文将对CYP450中的几种重要的代谢酶亚型CYP2C9、CYP2C19、CYP3A4的基本结构、基因多态性、种族差异及其对磺脲类降糖药代谢的影响作一综述。
|
| 关 键 词： | CYP2C9 CYP2C19 CYP3A4 磺脲类降糖药 药物代谢 |
| 收稿时间： | 2012-01-03 |
| 修稿时间： | 2012-04-24 |
Effect of CYP2C9, CYP2C19, CYP3A4 polymorphism on metabolism of sulfonyluea antidiabetic drugs |
| |
| LI Yun,HE Fang,ZENG Cai-wen,LIU Lin-lin,XIA Chun-hua.Effect of CYP2C9, CYP2C19, CYP3A4 polymorphism on metabolism of sulfonyluea antidiabetic drugs[J].Acta Metallurgica Sinica,2012,17(5):582-587. |
| |
| Authors: | LI Yun HE Fang ZENG Cai-wen LIU Lin-lin XIA Chun-hua |
| |
| Affiliation: | 1.Institute of Clinical Pharmacology, Medical College of Nanchang University,Nanchang 330006, Jiangxi,China;2.Jiangxi Nursing Occupation Technology College, Nanchang 330201, Jiangxi,China |
| |
| Abstract: | Sulfonylurea oral antidiabetic drugs were mainly metabolized by hepatic cytochrome P450 in human.Cytochrome P450 is one kind of important drug metabolizing enzymes in human and exhibits genetic polymorphism, which usually results in the difference of efficacy and adverse reaction among individuals.The purpose of this paper was to review the basic structure, genetic polymorphism and ethnic difference of CYP2C9, CYP2C19, CYP3A4 and the influence to sulfonylurea metabolism. |
| |
| Keywords: | CYP2C9 CYP2C19 CYP3A4 Sulfonylurea antidiabetic drugs Drug metabolism |
|
| 点击此处可从《金属学报》浏览原始摘要信息 |
|
点击此处可从《金属学报》下载全文 |
|
